Abstract
Proteins with intrinsic mitogenic properties are widely represented in prokaryotes, such as in different Streptococcus species (1–3), Candida albicans (4), and Eikenella corrodens (5). Specifically, several bacterial porins of Escherichia coli, Shigella dysenteriae, Salmonella typhimurium, Fusobacterium nucleatum, and pathogenic Neisseria species have been shown to induce nonspecific proliferation of lymphocytes (6–12).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferreira, P., Brás, A., Tavares, D., Vilanova, M., Ribeiro, A., Videira, A. and Arala-Chaves, M. P. (1997) Purification, and biochemical and biological characterization of an immunosuppressive and lymphocyte mitogenic protein secreted by Streptococcus sobrinus. Int. Immunol. 9, 1735–1743.
Arala-Chaves, M. P., Ribeiro, A. S., Santarem, M. M., and Coutinho, A. (1986) Strong mitogenic effect for murine B lymphocytes of an immunosuppressor substance released by Streptococcus intermedius. Infect. Immun. 54, 543–548.
Santarem, M. M., Porto, M. T., Ferreira, P., Soares, R., and Arala-Chaves, M. P. (1987) Semi-purification of an immunosuppressor substance secreted by Streptococcus mutans that plays a role in the protection of the bacteria in the host. Scand. J. Immunol. 26, 755–761.
Tavares, D., Salvador, A., Ferreira, P., and Arala-Chaves, M. P. (1993) Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host. Infect. Immun. 61, 1881–1888.
Proqulske, A., Mishell, R., Trummel, C., and Holt, S. C. (1984) Biological activities of Eikenella corrodens outer membrane and lipopolysaccharide. Infect. Immun. 43, 178–182.
Roy, S. and Biswas, T. (1996) Murine splenocyte proliferation by porin of Shigella dysenteriae type 1 and inhibition of bacterial invasion of HeLa cell by antiporin antibody. FEMS Microbiol. Lett. 141, 25–29.
Vordermeier, H.-M. and Bessler, W. G. (1987) Polyclonal activation of murine B lymphocytes in vitro by Salmonella typhimurium porins. Immunobiology 175, 245–251.
Vordermeier, H.-M., Drexler, H., and Bessler, W. G. (1987) Polyclonal activation of human peripheral blood lymphocytes by bacterial porins and defined porin fragments. Immunol. Lett. 15, 121–126.
Otsuka, J. (1986) Immunobiological activity of 41K protein (porin) derived from the cell envelope of Fusobacterium nucleatum. Nippon Shishubyo Gakkai Kaishi 28, 445–467.
Minetti, C. A. S. A., Tai, J. Y., Blake, M. S., Pullen, J. K., Liang, S. M., and Remeta, D. P. (1997) Structural and functional characterization of a recombinant PorB class 2 protein from Neisseria meningitidis. Conformational stability and porin activity. J. Biol. Chem. 272, 10,710–10,720.
Liu, M. A., Friedman, A., Oliff, A. I., Tai, J., Martinez, D., Deck, R. R., et al. (1992) A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes. Proc. Natl. Acad. Sci. USA 89, 4633–4637.
Ulmer, J. B., Burke, C. J., Shi, C., Friedman, A., Donnelly, J. J., and Liu, M. A. (1992) Pore formation and mitogenicity in blood cells by the class 2 protein of Neisseria meningitidis. J. Biol. Chem. 267, 19,266–19,271.
Melancon, J., Murgita, R. A., and DeVoe, I. W. (1983) Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens. Infect. Immun. 42, 471–479.
Wetzler, L. M., Ho, Y., and Reiser, H. (1996) Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J. Exp. Med. 183, 1151–1159.
Poolman, J. T. (1995) Development of a meningococcal vaccine. Infect. Agents Dis. 4, 13–28.
Fusco, P. C., Michon, F., Laude-Sharp, M., Minetti, C. A. S. A., Huang, C.-H., Heron, I., and Blake, M. S. (1998) Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine 16, 1842–1849.
Arala-Chaves, M. P. (1992) Is prophylactic immunostimulation of the host against pathogenic microbial antigens an adequate strategy of immunoprotection? Scand. J. Immunol. 35, 495–500.
Müller, A., Günther, D., Düx, F., Naumann, M., Meyer, T. F., and Rudel, T. (1999) Neisserial porin (PorB) causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine proteases. EMBO J. 18, 339–352.
Donnelly, J. J., Deck, R. R., and Liu, M. A. (1990) Immunogenicity of Haemophilus influenzae polysaccharide: Neisseria meningitidis outer membrane protein complex conjugate vaccine. J. Immunol. 145, 3071–3079.
Giebink, G. S., Koskela, M., Vella, P. P., Harris, M., and Le, C. T. (1993) Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media. J. Infect. Dis. 167, 347–355.
Paradiso, P. R. and Lindbberg, A. A. (1996) Glycoconjugate vaccines: future combinations. Dev. Biol. Stand. 87, 269–275.
Mackinnon, F. G., Ho, Y., Blake, M. S., Michon, F., Chandraker, A., Sayegh, M. H., and Wetzler, L. M. (1999) The role of B/T costimulatory signals in the immunopotentiating activity of Neisserial porin. J. Infect. Dis. 180, 755–761.
Fusco, P. C., Michon, F., Tai, J. Y., and Blake, M. S. (1998) Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates. J. Infect. Dis. 175, 364–372.
Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Huffel, C. V., Du, X., et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088.
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443–451.
Poltorak, A., Smirnova, I., He, X., Liu, M. Y., van Huffel, C., McNally, O., et al. (1999) Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 25, 78.
Robinson, J. H., Pyle, G., and Kehoe, M. A. (1992) Influence of major histocompatibility complex haplotype on the mitogenic response of T cells to staphylococcal enterotoxin B. Infect. Immun. 59, 3667–3672.
Kleijmeer, M. J., Ossevoort, M. A., van Veen, C. J. H., van Hellemond, J. J., Neefjes, J. J., Kast, W. M., et al. (1995) MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells. J. Immunol. 154, 5715–5724.
Kruisbeek, A. M. (1994) In vitro assays for lymphocyte function, in Current Protocols in Immunology (Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., and Strober, W., eds.), John Wiley and Sons, Inc., New York, pp. 3.0.1–3.19.7.
Calvin, F., Freeman, G. J., Razi-Wolf, Z., Hall, W. Jr., Benacerraf, B., Nadler, L., and Reiser, H. (1992) Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J. Immunol. 149, 3802–3808.
Li, H., Llera, A., Malchiodi, E. L., and Mariuzza, R. A. (1999) The structural basis of T cell activation by superantigens. Ann. Rev. Immunol. 17, 435–466.
McConkey, D. J., Zhivotovsky, B., and Orrenius, S. (1996) Apoptosis: molecular mechanisms and biological implications. Mol. Aspects Med. 17, 1–110.
FadoK, V. A., Warner, M. L., Bratton, D. L., and Henson, P. M. (1998) CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (α v β 3). J. Immunol. 161, 6250–6257.
Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184, 39–51.
Blake, M. S. and Gotschlich, E. C. (1982) Purification and partial characterization of the major outer membrane protein of Neisseria gonorrhoea. Infect. Immun. 36, 277–283.
Lytton, E. J. and Blake, M. S. (1986) Isolation and partial characterization of the reduction-modifiable protein of Neisseria gonorrhoea. J. Exp. Med. 164, 1749–1759.
Wetzler, L. M., Blake, M. S., and Gotschlich, E. C. (1988) Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations. J. Exp. Med. 168, 1883–1897.
Wetzler, L. M., Gotschlich, E. C., Blake, M. S., and Koomey, J. M. (1989) The construction and characterization of Neisseria gonorrhoeae lacking protein III in its outer membrane. J. Exp. Med. 169, 2199–2209.
Guttormsen, H.-K., Wetzler, L. M., and Solberg, C. O. (1994) Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease. Infect. Immun. 62, 1437–1443.
Guttormsen, H.-K., Wetzler, L. M., and Næss, A. (1993) Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease. Infect. Immun. 61, 4734–4742.
Klugman, K. P., Gotschlich, E. C., and Blake, M. S. (1989) Sequence of the structural gene (rmpM) for the class 4 outer membrane protein of Neisseria meningitidis, homology of the protein to gonococcal protein III and Escherichia coli OmpA, and construction of meningococcal strains that lack class 4 protein. Infect. Immun. 57, 2066–2071.
Tommassen, J., Vermeij, P., Struyve, M., Benz, R., and Poolman, J. T. (1990) Isolation of Neisseria meningitidis mutants deficient in class 1 (PorA) and class 3 (PorB) outer membrane proteins. Infect. Immun. 58, 1355–1359.
Otten, G., Yokohoma, Y. M., and Holmes, K. L. (1994) Immunofluorescence and cell sorting, in Current Protocols in Immunology (Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., and Strober, W., eds.), John Wiley and Sons, Inc., New York, pp. 5.0.1–5.8.8.
Bjune, G., Høiby, E. A., Grønnesby, J. K., Arnesen, O., Fredriksen, J. H., Halstensen, A., et al. (1991) Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338, 1093–1096.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Delvig, A.A., Robinson, J.H., Wetzler, L. (2001). Testing Meningococcal Vaccines for Mitogenicity and Superantigenicity. In: Pollard, A.J., Maiden, M.C. (eds) Meningococcal Vaccines. Methods in Molecular Medicine™, vol 66. Humana Press. https://doi.org/10.1385/1-59259-148-5:199
Download citation
DOI: https://doi.org/10.1385/1-59259-148-5:199
Publisher Name: Humana Press
Print ISBN: 978-0-89603-801-1
Online ISBN: 978-1-59259-148-0
eBook Packages: Springer Protocols